Read more

March 17, 2022
1 min read
Save

Potentially low-value services for low back pain decreased from 2011 to 2019

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Published results showed a decrease in the use of potentially low-value services among patients with low back pain, with reductions in the use of surgery, opioids and imaging from 2011 to 2019.

Perspective from Ali H. Mesiwala, MD, FAANS

Using administrative claims data from the HealthCore Integrated Research Environment, researchers identified 2,196,761 patients who had repeated claims for low back pain (LBP) at least 8 weeks apart from 2011 to 2019. Researchers considered utilization of services considered potentially low value by the International Association for the Study of Pain, including ED visits, liberal use of diagnostic imaging, opioids, spinal injections and surgery, as the primary outcomes. Researchers also examined all-cause inpatient stays, defined as hospitalizations for at least 1 night, and described inflation-adjusted per-patient-per-month allowed costs over time.

OT0222Pham_Graphic_01
Results showed a decrease in utilization of potentially low value services for low back pain from 2011 to 2019, including surgery use from 4.5% to 3.3%, opioids from 24.9% to 19.4% and imaging from 73.6% to 59.9%. Data were derived from Pham T, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2021.47178.

Results showed the use of inpatient services decreased from 12.4% to 9.3% from 2011 to 2019. Researchers also found a decrease in surgery use from 4.5% to 3.3%, use of opioids among patients from 24.9% to 19.4% and use of imaging from 73.6% to 59.9% during the same period, while use of epidural injections remained similar. Total per-patient-per-month costs decreased from $1,216 to $1,101 and inpatient per-patient-per-month costs decreased from $454 to $355 from 2011 to 2019, according to results. Researchers noted surgery, opioids and imaging had notable decreases in costs.

“The study was limited by possible miscoding, unknown use of services and medications billed outside of insurance, and unknown pain severity,” the authors wrote. “Trends in the use of potentially low-value services for LBP among commercially insured patients with LBP appear to be moving in a desirable direction.”